Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andreas Muhs
Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting With Targets Other Than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Related publications
Treatment of Dementias: Current Approaches and Disease Modifying Drugs
Journal of Nihon University Medical Association
P2Y Purinergic Receptors: New Targets for Analgesic and Antimigraine Drugs
Biochemical Pharmacology
Biochemistry
Pharmacology
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Disease Modifying Treatments and Symptomatic Drugs for Cognitive Impairment in Multiple Sclerosis: Where Do We Stand?
Multiple Sclerosis and Demyelinating Disorders
Allergy
Immunology
Neurology
Patient Preferences in the Choice of Disease Modifying Anti-Rheumatic Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Metabolism of Drugs With Inhibition of Enzymes
Journal of Drug Metabolism & Toxicology
Nanoparticle System for the Local Delivery of Disease Modifying Osteoarthritic Drugs
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
The Choice Of, and the Decision to Apply, Disease Modifying Drugs.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Persistence With Biological Disease-Modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
Drugs - Real World Outcomes
Pharmacology